DGXMEDIUM SIGNALOPERATIONAL10-K

DGX showed strong operational performance with gross profit surging 201% and significantly increased share buybacks of $450M, though declining cash reserves warrant monitoring.

The dramatic gross profit improvement suggests successful margin expansion initiatives or accounting changes that merit closer examination. The tripling of share buybacks to $450M combined with declining cash reserves indicates an aggressive capital return strategy that could constrain financial flexibility if operational momentum slows.

Comparing 2026-02-26 vs 2025-02-20View on EDGAR →
FINANCIAL ANALYSIS

DGX delivered robust top-line growth of 11.8% to $11.0B with exceptional gross profit expansion of 201% to $3.6B, driving net income growth of 13.9% to $992M and operating cash flow improvement of 41.4% to $1.9B. However, the company significantly increased share buybacks to $450M while cash declined 23.5% to $420M, suggesting an aggressive capital allocation strategy. The combination of strong operational performance and higher capital expenditures (+24%) points to a company investing for growth while aggressively returning capital to shareholders.

FINANCIAL STATEMENT CHANGES
Gross Profit
P&L
+201.2%
$1.2B→$3.6B

Gross profit expanding — improving pricing power or product mix shift toward higher-margin offerings.

Share Buybacks
Cash Flow
+198%
$151.0M→$450.0M

Share repurchases increased 198% — management returning capital, signals confidence in intrinsic value.

Net Interest Income
P&L
-48%
$25.0M→$13.0M

Net interest income declined 48% — margin compression from rate changes or funding cost increases.

Operating Cash Flow
Cash Flow
+41.4%
$1.3B→$1.9B

Operating cash flow surged 41.4% — exceptional cash generation, highest quality earnings signal.

Capital Expenditure
Cash Flow
+24%
$425.0M→$527.0M

Capex increased 24% — ongoing investment in capacity or infrastructure for future growth.

Cash & Equivalents
Balance Sheet
-23.5%
$549.0M→$420.0M

Cash decreased 23.5% — monitor burn rate and upcoming capital needs.

Operating Income
P&L
+15.6%
$1.3B→$1.6B

Operating income improving — cost discipline or growing revenue base absorbing fixed costs.

Net Income
P&L
+13.9%
$871.0M→$992.0M

Net income grew 13.9% — bottom-line growth signals improving overall business health.

Revenue
P&L
+11.8%
$9.9B→$11.0B

Revenue growing 11.8% — solid top-line momentum, watch margins for quality of growth.

SG&A Expense
P&L
+11.1%
$1.8B→$2.0B

SG&A increased modestly — likely reflects growth-related hiring or sales expansion investment.

LANGUAGE CHANGES
NEW — 2026-02-26
PRIOR — 2025-02-20
ADDED
As of February 2, 2026, there were outstanding 109,866,320 shares of the registrant s common stock, $.01 par value.
Management's Discussion and Analysis of Financial Condition and Results of Operations 46 Item 7A.
Large physician practices value our ability to standardize services on a national or regional scale.
In 2025, we generated approximately $1.2 billion in revenue from reference testing, where we perform testing that hospitals do not perform in their own in-hospital labs.
In 2025, our Collaborative Lab Solutions (formerly known as Professional Laboratory Services) offering generated approximately $800 million in revenues and management fees supporting hospitals in the operation of their own labs.
+7 more — sign up free →
REMOVED
As of January 31, 2025, there were outstanding 110,978,069 shares of the registrant s common stock, $.01 par value.
Management's Discussion and Analysis of Financial Condition and Results of Operations 45 Item 7A.
In 2024, we generated over $1 billion in revenue from reference testing, where we perform testing that hospitals do not perform in their own in-hospital labs.
In 2024, our Professional Laboratory Services offering generated approximately $800 million in revenues and management fees supporting hospitals in the operation of their own labs.
Our key Professional Laboratory Services offerings include lab management outsourcing, test menu optimization and spend consolidation, supply chain management and providing, advanced data solutions.
+7 more — sign up free →
MORE OPERATIONAL SIGNALS
HOFTHIGHHOFT completed a major divestiture of its Pulaski and Samuel Lawrence furniture ...
2026-04-17
CTRNHIGHCTRN underwent a dramatic operational turnaround with a complete repositioning f...
2026-04-15
ORBSHIGHORBS has undergone a complete business transformation from packaging and e-comme...
2026-04-15
BRFHHIGHBRFH completed a transformative acquisition of Arps Dairy in October 2025, drama...
2026-04-15
ANALYZE ANY FILING FREE

See what changed in your portfolio's filings

500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.

Try Tracenotes free →